Moreover, a number of these agents induce MPT targeting MPTP components that are selectively up-regulated in cancer cells, such as the TSPO and ANT proteins [15-18], thus reinforcing the cancer selective action of the therapy. This evidence concerns the gene TSPO and cancer.